Drug Information Association Logo


Dr. Nancy Dreyer is Global Chief of Scientific Affairs for Quintiles Outcome, the Real-World and Late Phase Research division of Quintiles. Nancy has more than 25 years experience in the design, conduct and interpretation of pharmacoepidemiologic research. She was CEO of Epidemiology Resources, Inc., a job she held from the company’s inception through its acquisition 20 years later by UnitedHealth Group. In that role, she launched the peer reviewed journal, Epidemiology. At Quintiles Outcome, she heads a team of researchers who design, conduct, and interpret research on comparative effectiveness and safety, and quality improvement programs, using prospective data collection as well as drawing on large electronic medical records datasets. She also leads the GRACE Initiative which is developing guidance on Good Research Practices for Observational Studies of Comparative Effectiveness (www.graceprinciples.org). Her recent experience includes participating on the Steering Committee for the European Medicines Agency’s PROTECT Project for the Innovative Medicines Initiative and Teaching for the FDA. She is a senior editor of the AHRQ handbook, “Registries for Evaluating Patient Outcomes: A User’s Guide,” now in its second edition. Also, she led the successful creation of a global patient registry for avian influenza, which resulted in the largest collection of case data available anywhere. Nancy is a Fellow and Board Member of the International Society of Pharmacoepidemiology and a member emeritus of the Dean’s Public Health Advisory Council for the University of North Carolina School of Public Health.